1. Medication Update.
- Subjects
- *
ADRENERGIC beta agonists , *IMMUNOLOGICAL adjuvants , *SUMATRIPTAN , *NAPROXEN , *BRONCHODILATOR agents , *OBSTRUCTIVE lung diseases , *MIGRAINE , *MULTIPLE sclerosis , *PATIENT-controlled analgesia , *POSTOPERATIVE pain , *TRANSDERMAL medication , *DRUG approval , *THERAPEUTICS - Abstract
The article offers information on several drugs approved by the U.S. Food and Drug Administration as of September 2015 including Treximet for migraine from Pernix Therapeutics Holdings Inc., Stiolto Respimat for chronic obstructive pulmonary disease, and a generic drug for multiple sclerosis.
- Published
- 2015
- Full Text
- View/download PDF